Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression

Max Lenz(Ludwig Boltzmann Institute for Digital Health and Prevention), Walter S. Speidl(University of Applied Sciences St Pölten), Johann Wojta(Medical University of Vienna), Laura Goederle(Medical University of Vienna), Nadine Maier(Medical University of Vienna), Philipp J. Hohensinner(Ludwig Boltzmann Institute for Age Research), Patrick Haider(Medical University of Vienna), Christoph J. Binder(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna), Konstantin A. Krychtiuk(Ludwig Boltzmann Institute for Cardiovascular Research), Mira Brekalo(Medical University of Vienna), Christian Hengstenberg(Medical University of Vienna)
Biomedicines
January 27, 2021
10.3390/biomedicines9020120
Cited by 22

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755